ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,691Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 403

$897K Total Retail Price of All Prescriptions

Rank: 10 out of 403

392 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

33% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

3% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 11,994 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 593 526 1 12
FUROSEMIDE 537 490 2 7
METOPROLOL TARTRATE 450 406 3 10
LEVOTHYROXINE SODIUM 412 395 4 3
TRAZODONE HCL 394 349 5 25
LISINOPRIL 312 295 6 1
GABAPENTIN 292 234 7 17
SERTRALINE HCL 274 262 8 20
CITALOPRAM HBR 265 260 9 22
SIMVASTATIN 253 224 10 2
OXYCODONE HCL 239 179 S2 11 39
MIRTAZAPINE 215 201 12 38
DONEPEZIL HCL 213 202 13 23
ISOSORBIDE MONONITRATE ER 200 172 14 62
RISPERIDONE 197 157 15 48
ESCITALOPRAM OXALATE 197 178 15 36
OMEPRAZOLE 175 171 17 9
POTASSIUM CHLORIDE 168 151 18 37
AMLODIPINE BESYLATE 166 156 19 4
SPIRIVA 164 139 20 35
OLANZAPINE 161 149 21 77
ADVAIR DISKUS 161 128 21 33
JANUVIA 159 145 23 44
DIVALPROEX SODIUM 152 152 24 64
CYMBALTA 147 138 25 43
TAMSULOSIN HCL 146 146 26 27
QUETIAPINE FUMARATE 141 120 27 52
LIDODERM 136 122 28 74
BACLOFEN 133 86 29 110
METFORMIN HCL 133 128 29 8
LANTUS 131 109 31 54
PREDNISONE 130 111 32 34
NAMENDA 120 120 33 41
CARVEDILOL 115 109 34 32
EXELON 111 111 35 114
METOPROLOL SUCCINATE 110 89 36 11
RANITIDINE HCL 103 93 37 46
IPRATROPIUM-ALBUTEROL 100 93 38 120
FINASTERIDE 91 78 39 82
CARBIDOPA-LEVODOPA 86 86 40 78
DIVALPROEX SODIUM ER 82 46 41 152
OXYCODONE-ACETAMINOPHEN 80 75 S2 42 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 56 43 106
DIOVAN 78 78 43 24
ALLOPURINOL 76 74 45 31
ATORVASTATIN CALCIUM 72 63 46 5
ABILIFY 69 59 47 134
HYDRALAZINE HCL 67 67 48 115
NOVOLIN N 64 64 49 231
HYDROCHLOROTHIAZIDE 62 62 50 6
DIGOXIN 61 61 51 56
NOVOLOG 61 52 51 117
POLYETHYLENE GLYCOL 3350 60 59 53 60
LEVOFLOXACIN 56 49 54 99
HYDROMORPHONE HCL 56 33 S2 54 150
SINGULAIR 56 56 54 65
BENZTROPINE MESYLATE 55 24 R 57 143
VOLTAREN 55 46 57 182
CARBAMAZEPINE 55 46 57 101
OXYCONTIN 54 40 S2 60 63
HUMALOG 54 34 60 151
CIPROFLOXACIN HCL 54 49 60 130
LEXAPRO 53 50 63 136
NOVOLIN 70-30 51 49 64 263
ZOLPIDEM TARTRATE 51 49 64 16
OXYBUTYNIN CHLORIDE ER 51 47 64 119
ATENOLOL 50 50 67 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.